La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Hyliion Holdings a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Hyliion Holdings..

Hyliion Holdings (AMEX:HYLN) Azioni, Catena delle Opzioni

Hyliion Holdings

Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

Envoy Medical, Inc. - Class A Common Stock

COCH

HYLN

SXTP

Scopri le penny stock sotto i $5 in cui Hyliion e altri due titoli stanno attirando l&#39;attenzione degli insider.

Penny stock sotto i $5: Hyliion e altri 2 titoli sotto osservazione

Hyliion Holdings Corp. Class A Common Stock

Hyliion Holdings Corp

Scotiabank analyst Nicholas Yulico upgrades Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>) from Sector Perform to Sector Outperform and lowers the price target from $333 to $305.

Upgrades

Price Target

Analyst Ratings

Scotiabank Upgrades Public Storage to Sector Outperform, Lowers Price Target to $305

The 10 wealthiest individuals in the world, including&nbsp;Elon Musk, CEO of&nbsp;Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), have lost $174 billion following President Donald Trump&#8216;s tariff announcement on April 2. On a year-to-date basis, they lost nearly a staggering $350 billion.
What Happened: Following Trump&#8217;s tariff declaration last Wednesday, the S&amp;P 500 plummeted 11%. This resulted in a significant shrinkage of the equity stakes of the world&#8217;s richest, who had a combined net worth exceeding&nbsp;$2 trillion at the start&nbsp;of 2025. 
As per the Bloomberg Billionaires Index, since the tariff announcement on April 2, Elon Musk and Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) CEO Mark Zuckerberg saw the maximum decline, with Musk losing $33 billion, while Zuckerberg lost $26 billion. Amazon&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Jeff Bezos saw a decline of $21 billion, while Oracle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NASDAQ">ORCL</a>) CEO Larry Ellison witnessed a $20 billion drop in their net worth.
Google (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) founders, Larry Page and Sergey Brin, lost $12 billion and $11 billion, each. Former Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) CEOs Bill Gates and Steve Balmer saw their fortune decline by $15 billion and $9 billion, respectively.
Meanwhile, Bernard Arnault, the French billionaire and CEO of the luxury brand LVMH, lost $14 billion of his net worth.
Surprisingly, legendary investor and chief of Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), Warren Buffett&#8217;s net worth also fell by $13 billion since Trump&#8217;s tariff announcement on April 2. However, Buffett maintained a positive net worth year-to-date.
Why It Matters: On Monday, Musk&#8217;s <a href="https://www.benzinga.com/markets/25/04/44700935/elon-musks-net-worth-dives-below-300-billion-for-the-first-time-since-november-amid-tesla-attacks-an">net worth dipped </a>below $300 billion, a level unseen since the previous year. The Bloomberg Billionaires Index indicated that Musk&#8217;s wealth was $298 billion at Monday&#8217;s market close, marking a reduction of nearly $135 billion, or 31%, since the beginning of the year.
Meanwhile, President Trump&#8217;s <a href="https://www.benzinga.com/markets/25/04/44706255/trump-loses-500-million-in-personal-wealth-as-his-own-tariff-policy-sparks-sharp-declines-across-his-business-empire">net worth </a>also took a significant hit post the implementation of his extensive new tariffs. Within days, Trump's estimated net worth declined by nearly $600 million, falling from $4.7 billion to $4.1 billion, as per Forbes&#8217; analysis.
President Trump&#8217;s sweeping tariffs, announced on April 2, sparked market turmoil. The next day, stocks endured their worst single-day decline in five years, with the S&amp;P 500 falling nearly 5%, the Dow dropping 1,679 points, and the Nasdaq plummeting 6%.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/trading-ideas/long-ideas/25/04/44697177/marjorie-taylor-greene-buys-the-dip-congresswoman-purchases-shares-of-apple-amazon-nike-" target="_blank" rel="noreferrer noopener">Marjorie Taylor Greene Buys The Dip: Congresswoman Purchases Shares Of Apple, Amazon, Nike And More Following Tariff-Related Sell-Off</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

AMZN

GOOG

GOOGL

MSFT

ORCL

TSLA

Trump's Tariff Turmoil Topples Ultra-Rich's Wealth — $174B Wiped Out From Fortunes Of World's Top 10 Billionaires, Including Elon Musk, Warren Buffett And Mark Zuckerberg

Tempest Therapeutics, Inc. - Common Stock

TPST

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) shares are trading higher premarket after the company reported better-than-expected <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44707201/delta-air-lines-announces-march-quarter-2025-financial-results" rel="noreferrer noopener">first-quarter 2025 results</a>.
Delta reported fourth-quarter operating revenue growth of 2% year-over-year to $14.04 billion, beating the consensus of $13.02 billion. Adjusted operating revenue was $12.98 billion (+3.3% YoY)
The adjusted average fuel price was $2.47 per gallon, down from $2.79 in last year&#8217;s quarter. Adjusted EPS was $0.46 (+2% YoY), beating the consensus of $0.38.
Related: <a target="_blank" href="https://www.benzinga.com/25/04/44705362/top-wall-street-forecasters-revamp-delta-air-lines-price-expectations-ahead-of-q1-earnings" rel="noreferrer noopener">Top Wall Street Forecasters Revamp Delta Air Lines Price Expectations Ahead Of Q1 Earnings</a>
Total passenger revenue for the quarter grew 3% year over year to $11.48 billion; cargo revenue grew 17% year over year to $208 million, and Other revenue was $2.352 billion (-4% year over year).
Delta recorded an adjusted operating income of $591 million, down from $640 million YoY, with an adjusted operating margin of 4.6%, down 50 bps.
Adjusted operating expenses increased by 4% YoY to $12.388 billion, and Adjusted Non-fuel costs were $9.875 billion (+7% YoY) for the quarter.
Delta generated an adjusted operating cash flow of $2.44 billion (-1% Y/Y) in the March quarter, and free cash flow stood at $1.28 billion.
As of the March quarter, Delta reported adjusted net debt of $16.9 billion, down $1.1 billion from year-end 2024. Total liquidity was $6.8 billion, including $3.1 billion in undrawn revolver capacity.
The passenger load factor dropped 81.4% from 82.7% last year. DAL&#8217;s Air Traffic Liability ended the quarter at $10 billion.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/travel/25/04/44671680/which-us-airline-is-facing-the-strongest-industry-tailwinds" rel="noreferrer noopener">Which US Airline Faces The Strongest Industry Tailwinds?</a>
Delta&#8217;s Chief Financial Officer, Dan Janki, noted that the company delivered better-than-expected results despite early-year weather challenges. &#8220;Our teams ran a strong operation… enabling us to drive efficiency and deliver non-fuel unit cost growth of up 2.6 percent over prior year,&#8221; he said. Janki added that as Delta reduces capacity growth, it is &#8220;taking incremental action to manage costs,&#8221; and expects non-fuel unit cost growth to align with its long-term target of low-single-digit increases in the second quarter and beyond.
&#8220;With broad economic uncertainty around global trade, growth has largely stalled.&nbsp;In this slower-growth environment, we are protecting margins and cash flow by focusing on what we can control.&nbsp;This includes reducing planned capacity growth in the second half of the year to flat over last year while actively managing costs and capital expenditures,&#8221; commented Ed Bastian, Delta&#8217;s chief executive officer.
&#8220;We expect June quarter profitability of $1.5 to $2 billion.&nbsp;Given the lack of economic clarity, it is premature at this time to provide an updated full-year outlook.&nbsp;Given our position of strength, our bias toward action, and the decline in fuel prices, Delta remains well positioned to deliver solid profitability and free cash flow for the year. I expect that our financial results will continue to lead the industry and validate our strategy to create differentiation and greater financial durability,&#8221; added Bastian.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44634938/airline-earnings-at-risk-as-demand-dips-amid-weak-business-travel-low-transborder-traffic-doge-cuts-analyst-says" rel="noreferrer noopener">Airline Earnings At Risk As Demand Dips Amid Weak Business Travel, Low Transborder Traffic, DOGE Cuts: Analyst Says</a>
Second Quarter 2025 Outlook: DAL&#8217;s total revenue is expected to be down 2% to up 2% over the prior year, with an operating margin of 11%—14%.
Adjusted Earnings per share are forecasted between $1.70 and $2.30 versus the $2.39 estimate.
Delta is not reaffirming its full-year 2025 financial guidance and plans to provide an update later in the year as market visibility improves.
Price Action: DAL shares are trading lower by 0.45% at $35.73 premarket at the last check on Wednesday.
Image via Shutterstock

Earnings

Guidance

Delta Air Lines Wants To Protect Margins And Cash Flow Citing Economic Uncertainty, Does Not Reaffirm FY25 Outlook

RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) reported worse-than-expected third-quarter financial results on Tuesday.
Sales declined 3% year over year to $1.48 billion, missing the consensus of $1.51 billion. Adjusted EPS was 35 cents, missing the consensus of 49 cents.
Frank C. Sullivan, RPM chairman and CEO said, "Unseasonably cold weather in the southern U.S. and wildfires in the west reduced demand in geographies that typically have more construction and outdoor project activity in winter months."
"As we look toward the fourth quarter, macroeconomic conditions are challenging, but we are seeing pockets of positive momentum and are leveraging our focus on repair and maintenance in both construction and consumer end markets. As demonstrated in prior economic cycles, the ability of our products and services to extend asset life becomes even more attractive to end users when budgets are tight."
For the fourth quarter, RPM expects consolidated sales to remain flat compared to prior-year records.
RPM shares dipped 9.1% to close at $96.97 on Tuesday.
These analysts made changes to their price targets on RPM International following earnings announcement.
<ul>
<li>Baird analyst Ghansham Panjabi maintained RPM Intl with a Neutral and lowered the price target from $125 to $110.</li>
<li>BMO Capital analyst John McNulty maintained the stock with an Outperform rating and lowered the price target from $154 to $126.</li>
<li>Morgan Stanley analyst Vincent Sinisi maintained RPM with an Equal-Weight rating and cut the price target from $125 to $113.</li>
</ul>
Considering buying RPM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="590" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54-1024x590.png" alt="" class="wp-image-863776" style="width:522px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54-1024x590.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54-768x443.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

RPM International Analysts Slash Their Forecasts After Downbeat Earnings

BMO Capital analyst Andrew Strelzik maintains Dave &amp; Buster's Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>) with a Outperform and lowers the price target from $47 to $30.

PLAY

BMO Capital Maintains Outperform on Dave & Buster's Enter, Lowers Price Target to $30

Scotiabank analyst Ben Isaacson upgrades CF Industries Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) from Sector Underperform to Sector Perform and maintains the price target from $81 to $81.

Scotiabank Upgrades CF Industries Holdings to Sector Perform, Maintains Price Target to $81

Global fintech firm Broadridge Financial Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BR#NYSE">BR</a>) <a href="https://www.benzinga.com/pressreleases/25/04/n44704954/broadridge-collaborates-with-fnality-to-enable-real-time-settlement-for-intraday-repo-transactions">revealed it has concluded a successful joint effort</a> with blockchain payments company Fnality. 
The collaboration proved that Broadridge's Distributed Ledger Repo (DLR) platform can operate with Fnality's Payment System (FnPS), highlighting how tokenized assets can transform transaction processes in global financial markets.
Fnality is building a network of regulated wholesale payment systems powered by distributed ledger technology, each overseen by its local central bank. 
These systems, called Fnality Payment Systems (FnPS), allow participants to use digital versions of central bank funds for instant transactions. 
The partnership sets the stage for instant intraday repo settlements by utilizing tokenized money backed by central bank reserves.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44703031/this-beverage-maker-tobacco-company-and-packaged-food-giant-outshine-in-a-recession">This Beverage Maker, Tobacco Company And Packaged Food Giant Outshine In A Recession</a>
The combined use of Broadridge's DLR platform and Fnality's FnPS network illustrates how real-time delivery versus payment (DvP) can be achieved in repo markets. 
Leveraging tokenized funds tied to central bank reserves as the settlement foundation, the approach offers enhanced transaction speed and security. 
This development meets a critical industry demand for better liquidity management and lower risk in both the U.S. and European financial systems.
With planned rollouts in major markets, FnPS aims to support 24/7 cross-currency payments and atomic settlement, offering secure, institutional-grade digital cash for emerging digital asset markets.
Broadridge views this milestone as a major step toward broadening its digital footprint across Europe. The company aims to grow its DLR client base by offering near-instant settlement solutions to meet the increasing demand for speed and security in financial markets.
For its part, Fnality plans to extend its regulated blockchain-based wholesale payments infrastructure beyond the UK, targeting the U.S. as a critical expansion region.
Broadridge&#8217;s second-quarter 2025 sales grew <a href="https://www.benzinga.com/25/01/43394380/broadridge-financial-q2-beats-estimates-reaffirms-outlook">13.1% year-on-year to $1.589 billion</a>.
Broadridge provides technology solutions that support investing, corporate governance, and financial communications. Its platforms facilitate daily trades exceeding $10 trillion in securities and connect public companies with investors worldwide.
Price Action: BR shares closed lower by 1.32% at $217.22 on Tuesday.
Read Next: <a href="https://www.benzinga.com/tech/25/04/44695622/amazon-touts-ai-milestone-says-new-model-outshines-gpt-4o-in-real-time-speech">Amazon Touts AI Milestone, Says New Model Outshines GPT-4o In Real-Time Speech</a>
Photo: Shutterstock

General

Broadridge And Fnality Unlock Blockchain-Based Repo Settlements

Neogen Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOG#NASDAQ">NEOG</a>) reported third-quarter 2025 adjusted EPS of 10 cents on Wednesday, down from 12 cents a year ago, missing the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus of 11 cents</a>.
The company reported sales of $220.98 million, down 3.4% year over year, missing the consensus of $224.88 million.
Core revenue, which excludes the impacts of foreign currency translation and acquisitions completed and product lines discontinued in the last 12 months, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44707568/neogen-announces-third-quarter-2025-results" rel="noreferrer noopener">increased by 0.2%</a>.
Acquisitions and discontinued product lines had a negative impact of 0.5% while foreign currency had a negative impact of 3.1%.
The gross margin was 49.9% down from 51.1% a year ago, mainly due to lower revenue and higher integration costs. Excluding integration and restructuring costs, gross margin was 51.5% in the third quarter compared to 51.8% in the prior-year quarter.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44698463/cartesian-therapeutics-reports-strong-12-month-data-for-lead-cell-therapy-in-myasthenia-gravis-patients" rel="noreferrer noopener">Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients</a>
Third-quarter Adjusted EBITDA was $48.5 million, representing an adjusted EBITDA margin of 22%, compared with $52.7 million and a margin of 23% a year earlier.
Revenues for the Food Safety segment were $152.7 million, a decrease of 3.2%, consisting of 1.5% core growth, a negative 0.3% impact from discontinued product lines, and a negative foreign currency impact of 4.4%.
<ul>
<li>Core growth was driven largely by biosecurity and bacterial and general sanitation product categories, which benefited from strong growth in pathogen detection products.</li>
</ul>
Revenues for the Animal Safety segment were $68.2 million, a decrease of 4%, consisting of a 2.6% core revenue decline, an unfavorable 0.4% foreign currency impact and a negative 1% impact from discontinued product lines.
<ul>
<li>Growth was led by the animal care and other and biosecurity product categories, particularly in small-animal supplements, rodent control, and cleaner and disinfectant products, and offset by a decline in the vet instruments product category.</li>
</ul>
The company&#8217;s Genomics business experienced a core revenue decline in the mid-single-digit range. Increased sales into bovine markets were offset by declines in other areas, consistent with the focused restructuring activities executed in the second quarter.
Guidance: The company is updating its full-year outlook, primarily due to lower-than-expected third-quarter results, the rising level of macroeconomic uncertainty affecting the company&#8217;s end markets, and the expected impact of tariffs in the fourth quarter.
Neogen expects fiscal year 2025 sales of approximately $895 million, down from prior guidance of $905 million-$925 million and consensus of $910.23 million.
The company forecasts 2025 adjusted EBITDA of approximately $195 million compared to prior guidance of $205 million-$215 million.
Management Update: Neogen CEO John Adent will be stepping down after eight years the company. Adent will continue to serve in his existing roles until his successor <a href="https://www.benzinga.com/pressreleases/25/04/b44707614/neogen-announces-ceo-transition" target="_blank" rel="noreferrer noopener">has been appointed</a>.
Price Action: NEOG stock is down 17.6% at $5.80 during the premarket session at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44698379/argenxs-flagship-drug-vyvgart-shows-sustained-disease-control-in-rare-neuromuscular-disease-patients" target="_blank" rel="noreferrer noopener">Argenx&#8217;s Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients</a></li>
</ul>
Photo: Shutterstock/MacroEcon

Health Care

Management

Movers

NEOG

Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Barclays cut Americold Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COLD#NYSE">COLD</a>) price target from $26 to $21. Barclays analyst Anthony Powell upgraded the stock from Equal-Weight to Overweight. Americold Realty Trust shares closed at $17.50 on Tuesday. <a href="https://www.benzinga.com/quote/COLD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan slashed the price target for PTC Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) from $210 to $160. JP Morgan analyst Alexei Gogolev downgraded the stock from Overweight to Neutral. PTC shares closed at $136.74 on Tuesday. <a href="https://www.benzinga.com/quote/PTC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies lowered Xenia Hotels &amp; Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) price target from $18 to $10. Jefferies analyst David Katz downgraded the stock from Buy to Hold. Xenia Hotels shares closed at $9.22 on Tuesday. <a href="https://www.benzinga.com/quote/XHR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler cut the price target for Goosehead Insurance, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) from $132 to $122. Piper Sandler analyst Paul Newsome maintained an Overweight rating. Goosehead Insurance shares closed at $103.90 on Tuesday. <a href="https://www.benzinga.com/quote/GSHD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer cut the price target for Freshworks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) from $24 to $19. Oppenheimer analyst Brian Schwartz maintained an Outperform rating. Freshworks shares closed at $12.08 on Tuesday. <a href="https://www.benzinga.com/quote/FRSH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho raised UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) price target from $600 to $650. Mizuho analyst Ann Hynes maintained an Outperform rating. UnitedHealth shares settled at $553.08 on Tuesday. <a href="https://www.benzinga.com/quote/UNH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) price target from $17 to $16. Morgan Stanley analyst Alex Straton maintained an Equal-Weight rating. Levi Strauss shares closed at $12.42 on Tuesday. <a href="https://www.benzinga.com/quote/LEVI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho slashed Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) price target from $285 to $255. Mizuho analyst James Lee maintained an Outperform rating. Amazon shares closed at $170.66 on Tuesday.  <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital cut the price target for RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) from $154 to $126. BMO Capital analyst John McNulty maintained an Outperform rating. RPM shares settled at $96.97 on Tuesday. <a href="https://www.benzinga.com/quote/RPM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs raised Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) price target from $157 to $172. Goldman Sachs analyst Asad Haider upgraded the stock from Neutral to Buy. Johnson &amp; Johnson shares closed at $150.00 on Tuesday. <a href="https://www.benzinga.com/quote/JNJ/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying AMZN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-1024x584.png" alt="" class="wp-image-863746" style="width:544px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53.png 1080w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

COLD

FRSH

GSHD

LEVI

Amazon.com To $255? Here Are 10 Top Analyst Forecasts For Wednesday

Subcutaneous DARZALEX&reg; is co-formulated with Halozyme&#39;s ENHANZE&reg; drug delivery technology

Biotech

HALO

Halozyme Therapeutics Announces European Commission Approved Subcutaneous DARZALEX-Based Quadruplet Regimen For Treatment Of Patients With Newly Diagnosed Multiple Myeloma, Regardless Of Transplant Eligibility

Needham analyst Serge Belanger reiterates Collegium Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLL#NASDAQ">COLL</a>) with a Buy and maintains $46 price target.

Reiteration

COLL

Needham Reiterates Buy on Collegium Pharmaceutical, Maintains $46 Price Target

OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) reported quarterly losses of $(1.17) per share. This is a 178.57 percent decrease over losses of $(0.42) per share from the same period last year. The company reported $5.78 million in sales this quarter. This is a 0.46 percent decrease over sales of $5.81 million the same period last year.

OceanPal Q4 EPS $(1.17) Down From $(0.42) YoY, Sales $5.78M Down From $5.81M YoY

Apollo CEO Marc Rowan Says I Expect Over The Next 90 Days We'll See The Beginnings Of Countries Coming To Make Deals

SNDL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) ("SNDL") and 1CM Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/EPIC#CSE">EPIC</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/MILFF#OTCQB">MILFF</a>) (FSE: IQ70) ("1CM") are&nbsp;pleased to announce that they have&nbsp;entered into an arrangement&nbsp;agreement (the "Agreement") pursuant to which SNDL will acquire 32&nbsp;cannabis retail stores&nbsp;(the "Transaction")&nbsp;operating under the Cost Cannabis and T Cannabis banners in Ontario, Alberta and Saskatchewan (the "1CM Stores"). Unless otherwise specified herein, all amounts are in Canadian currency.
Under&nbsp;the terms of&nbsp;the Agreement, SNDL will acquire, with the option to assign, the 1CM Stores for total consideration (the "Purchase Price") of $32.2&nbsp;million in cash, subject to certain adjustments at the closing of the Transaction (the "Closing").&nbsp;The 1CM Stores are comprised of 2&nbsp;stores in Alberta, 3 stores&nbsp;in Saskatchewan and 27&nbsp;stores located in Ontario. The&nbsp;1CM&nbsp;Stores&nbsp;generated annual revenue of an aggregate&nbsp;of $53 million&nbsp;the fiscal year ended August 31, 2024 with 30 active stores at the fiscal year end.&nbsp;The acquisition of the 1CM Stores will bring SNDL's&nbsp;total owned and franchised cannabis retail store count to 219.

CSE:EPIC

MILFF

SNDL

SNDL Inc. To Acquire 32 Cannabis Retail Stores Operating Under Cost Cannabis And T Cannabis Banners In Ontario, Alberta, And Saskatchewan From 1CM Inc. For $32.2M, Increasing SNDL's Total Retail Store Count To 219

Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) with a Buy and maintains $60 price target.

Needham Reiterates Buy on Avidity Biosciences, Maintains $60 Price Target

Citigroup analyst Ryan Levine upgrades Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) from Neutral to Buy and lowers the price target from $334 to $232.

Citigroup Upgrades Constellation Energy to Buy, Lowers Price Target to $232

Electronics manufacturer Foxconn Technology Co <a href="https://www.benzinga.com/topic/japan" target="_blank" rel="noreferrer noopener">is eyeing Japanese</a> automakers, including Nissan Motor Co (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NSANY#OTC">NSANY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NSANF#OTC">NSANF</a>), to form a Japan-Taiwan alliance.
According <a href="https://asia.nikkei.com/Editor-s-Picks/Interview/Taiwan-s-Foxconn-hopes-to-work-with-Nissan-others-on-EV-production" target="_blank" rel="noreferrer noopener">to</a> Nikkei Asia, Foxconn EV chief strategy officer Jun Seki revealed the agreement during a <a href="https://www.benzinga.com/markets/asia/25/03/44508263/apple-and-nvidia-supplier-foxconn-to-present-ev-plans-at-japan-seminar-following-mitsubishi-deal-report" target="_blank" rel="noreferrer noopener">Tokyo seminar on</a> Tuesday.
Foxconn, also known as Hon Hai Precision (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HNHAY#OTC">HNHAY</a>), is currently competing with Chinese brands focused on battery-powered vehicles, looking to win market share in Europe, Brazil, and Thailand.
Foxconn, an Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) supplier, plans to launch an electric bus and a battery-powered microbus in Japan in 2027, Reuters cited Seki.
Also Read: <a href="https://www.benzinga.com/25/04/44631510/asml-to-boost-japan-workforce-5x-amid-global-race-for-advanced-semiconductor-tech" target="_blank" rel="noreferrer noopener">Chip Equipment Maker ASML To Boost Japan Workforce 5x Amid Global Race For Advanced Semiconductor Tech</a>
It focuses on providing business-to-business services with EV operations instead of targeting consumers directly.
Seki told Reuters that Foxconn should be part of a potential broader partnership with Honda Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>), Nissan, and Mitsubishi Motors (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MTSUY#OTC">MTSUY</a>) and confirmed that Foxconn was finalizing a deal with Mitsubishi to supply it with EVs.
Foxconn was working with Mitsubishi, Seki said during Wednesday&#8217;s event.
President Donald Trump&#8217;s 25% auto tariff&nbsp;<a target="_blank" href="https://www.benzinga.com/news/25/03/44522387/japanese-automakers-face-29-billion-tariff-hit-nissan-mazda-subaru-most-at-risk-says-analyst" rel="noreferrer noopener">threatens to disrupt</a> the global automotive industry, with analysts warning of sharp price increases and declining sales.
Goldman Sachs&nbsp;expected imported&nbsp;vehicle prices to surge by $5,000 to $15,000, while even U.S.-built cars could see cost hikes of $3,000 to $8,000 due to foreign-made parts. According to analyst Akira Kishimoto, Japanese automakers could face a potential hit of 4.46 trillion yen (about $29.44 billion).
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/25/04/44668137/nio-power-in-deal-talks-with-tesla-battery-supplier-catl" target="_blank" rel="noreferrer noopener">Nio Power In Deal Talks With Tesla Battery Supplier CATL</a></li>
</ul>
Image: Shutterstock

Asia

Global

Media

AAPL

HNHAY

MTSUY

NSANF

NSANY

Foxconn Eyes Nissan, Mitsubishi In Japan EV Push To Counter China's Growing Auto Threat

Needham analyst Gil Blum reiterates Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) with a Buy and maintains $42 price target.

RCKT

Needham Reiterates Buy on Rocket Pharmaceuticals, Maintains $42 Price Target

Needham analyst Mike Matson reiterates Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) from Hold to Hold.

Comments

Hyliion Holdings

Hyliion Holdings (HYLN) Opzioni

Hyliion Holdings (AMEX:HYLN) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO